A biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.
(SOURCE) https://www.cnn.com/2022/11/17/health/tzield-teplizumab-diabetic-treatment/index.html
FDA approves first treatment to delay onset of type 1 diabetes
Share: